Letter: Hypotension during administration of angiotensin converting enzyme inhibitor SQ 20,881. 1974

D W Duhme, and J Sancho, and C Athanasoulis, and E Haber, and J Koch-Weser

UI MeSH Term Description Entries
D006977 Hypertension, Renal Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN. Hypertensions, Renal,Renal Hypertension,Renal Hypertensions
D007022 Hypotension Abnormally low BLOOD PRESSURE that can result in inadequate blood flow to the brain and other vital organs. Common symptom is DIZZINESS but greater negative impacts on the body occur when there is prolonged depravation of oxygen and nutrients. Blood Pressure, Low,Hypotension, Vascular,Low Blood Pressure,Vascular Hypotension
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D011674 Pulse The rhythmical expansion and contraction of an ARTERY produced by waves of pressure caused by the ejection of BLOOD from the left ventricle of the HEART as it contracts. Pulses
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug

Related Publications

D W Duhme, and J Sancho, and C Athanasoulis, and E Haber, and J Koch-Weser
August 1974, Lancet (London, England),
D W Duhme, and J Sancho, and C Athanasoulis, and E Haber, and J Koch-Weser
January 1973, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
D W Duhme, and J Sancho, and C Athanasoulis, and E Haber, and J Koch-Weser
August 1982, Circulation research,
D W Duhme, and J Sancho, and C Athanasoulis, and E Haber, and J Koch-Weser
January 1981, Hypertension (Dallas, Tex. : 1979),
D W Duhme, and J Sancho, and C Athanasoulis, and E Haber, and J Koch-Weser
February 1979, Angiology,
D W Duhme, and J Sancho, and C Athanasoulis, and E Haber, and J Koch-Weser
June 1979, Endocrinologia japonica,
D W Duhme, and J Sancho, and C Athanasoulis, and E Haber, and J Koch-Weser
July 1990, Journal of cardiovascular pharmacology,
D W Duhme, and J Sancho, and C Athanasoulis, and E Haber, and J Koch-Weser
June 1980, Acta endocrinologica,
D W Duhme, and J Sancho, and C Athanasoulis, and E Haber, and J Koch-Weser
January 1973, Lancet (London, England),
D W Duhme, and J Sancho, and C Athanasoulis, and E Haber, and J Koch-Weser
July 1982, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!